blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2930242

EP2930242 - GENES ENCODING BIOFILM FORMATION INHIBITORY PROTEINS AND A METHOD FOR PRODUCING L-LYSINE USING A BACTERIAL STRAIN WITH THE INACTIVATED GENES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.09.2020
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  11.10.2019
FormerGrant of patent is intended
Status updated on  28.04.2019
FormerExamination is in progress
Status updated on  24.03.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
CJ Cheiljedang Corporation
Dongho-ro 330
Ssangnim-dong
Jung-gu
Seoul 100-400 / KR
[2015/42]
Inventor(s)01 / Ha, Un Hwan
603-901, 187, Noeundong-ro
Yuseong-gu
Daejeon 305-770 / KR
02 / Kim, YongJae
95-18, Seongyeong-ro
Seongbuk-gu
Seoul 136-846 / KR
03 / Lee, Jung Hoon
33, Nangye-ro 11-gil
Jung-gu
Seoul 100-871 / KR
04 / Shin, Hee Sung
106-103, 57, Deogyeong-daero 2077beon-gil
Giheung-gu
Yongin-si
Gyeonggi-do 446-908 / KR
05 / Moon, Jun Ok
102-807, 17, Woljeong-ro 9-gil
Yangcheon-gu
Seoul 158-090 / KR
06 / Kim, Hyung Joon
103-1403, 343, Gyeongin-ro
Guro-gu
Seoul 152-795 / KR
07 / Lee, Kwang Ho
809, 28, Hwagok-ro 68-gil
Gangseo-gu
Seoul 157-840 / KR
 [2015/42]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2019/46]Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Former [2015/42]Andrews, Robert, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date15164488.713.10.2014
[2015/42]
Priority number, dateKR2013012244315.10.2013         Original published format: KR 20130122443
[2015/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2930242
Date:14.10.2015
Language:EN
[2015/42]
Type: B1 Patent specification 
No.:EP2930242
Date:13.11.2019
Language:EN
[2019/46]
Search report(s)(Supplementary) European search report - dispatched on:EP06.07.2015
ClassificationIPC:C12N15/63, C07K14/34, C12N15/52
[2015/42]
CPC:
C12P13/08 (EP,CN,KR,US); C12N15/11 (KR); C07K14/34 (EP,CN,US);
C12N1/20 (EP,KR,US); C12N9/0014 (EP,US); C12N9/1025 (EP,US);
C12Y104/99001 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/20]
Former [2015/42]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:GENE ZUR CODIERUNG VON BIOFILMBILDUNGSHEMMENDEN PROTEINEN UND VERFAHREN ZUR HERSTELLUNG VON L-LYSIN MITTELS EINES BAKTERIELLEN STAMMS MIT DEN INAKTIVIERTEN GENEN[2015/42]
English:GENES ENCODING BIOFILM FORMATION INHIBITORY PROTEINS AND A METHOD FOR PRODUCING L-LYSINE USING A BACTERIAL STRAIN WITH THE INACTIVATED GENES[2015/42]
French:GÈNES CODANT DES PROTÉINES D'INHIBITION DE LA FORMATION DE BIOFILM ET PROCÉDÉ DE PRODUCTION DE L-LYSINE UTILISANT UNE SOUCHE BACTÉRIENNE AVEC LES GÈNES INACTIVÉS[2015/42]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure11.04.2016Amendment by applicant (claims and/or description)
11.04.2016Examination requested  [2016/20]
27.03.2017Despatch of a communication from the examining division (Time limit: M06)
05.10.2017Reply to a communication from the examining division
20.10.2017Despatch of a communication from the examining division (Time limit: M06)
30.04.2018Reply to a communication from the examining division
12.06.2018Despatch of a communication from the examining division (Time limit: M06)
21.12.2018Reply to a communication from the examining division
29.04.2019Communication of intention to grant the patent
02.09.2019Fee for grant paid
02.09.2019Fee for publishing/printing paid
02.09.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14188620.0  / EP2862932
Opposition(s)14.08.2020No opposition filed within time limit [2020/43]
Fees paidRenewal fee
24.10.2016Renewal fee patent year 03
25.10.2017Renewal fee patent year 04
25.10.2018Renewal fee patent year 05
03.10.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL13.11.2019
AT13.11.2019
CY13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
IT13.11.2019
LT13.11.2019
LV13.11.2019
MC13.11.2019
MK13.11.2019
MT13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
TR13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
[2022/32]
Former [2022/27]AL13.11.2019
AT13.11.2019
CY13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
IT13.11.2019
LT13.11.2019
LV13.11.2019
MC13.11.2019
MT13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
TR13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2021/31]AL13.11.2019
AT13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
IT13.11.2019
LT13.11.2019
LV13.11.2019
MC13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2021/10]AL13.11.2019
AT13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
IT13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/51]AL13.11.2019
AT13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/37]AL13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/36]AL13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/35]AL13.11.2019
CZ13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/34]AL13.11.2019
ES13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/32]AL13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/25]FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/24]FI13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/23]FI13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
GR14.02.2020
PT13.03.2020
Former [2020/22]FI13.11.2019
LT13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
PT13.03.2020
Former [2020/21]NO13.02.2020
Documents cited:Search[X]US3849250  (NAKAYAMA K, et al) [X] 1 * page 1, line 36 - line 40 *;
 [Y]EP1106693  (DEGUSSA [DE]) [Y] 1,2 * claims 7-16 *;
 [Y]EP1108790  (KYOWA HAKKO KOGYO KK [JP]) [Y] 1,2 * claims 51, 62, 64; sequence 3333 *;
 [X]DE10128510  (DEGUSSA [DE]) [X] 1 * page 12, paragraph 50; claim 1; sequence 2069 *;
 [Y]WO2012008810  (CJ CHEILJEDANG CORP [KR], et al) [Y] 1,2 * claims 1-10 *;
 [Y]EP2453006  (CJ CHEILJEDANG CORP [KR]) [Y] 1,2* claims 1-8 *;
 [T]  - SEOK HYUN PARK ET AL, "Metabolic engineering of Corynebacterium glutamicum for L-arginine production", NATURE COMMUNICATIONS, (20140805), vol. 5, doi:10.1038/ncomms5618, XP055197630 [T] * supplementary data 1 *

DOI:   http://dx.doi.org/10.1038/ncomms5618
 [X]  - KYUNG KI-CHEON ET AL., "Development of L-Lysine Producing Strains by Intergeneric Protoplast Fusion of Brevibacterium flavum and Corynebacterium glutamicum", KOR. J. APPL. MICROBIOL. BIOENG., (19850813), vol. 13, no. 3, pages 279 - 283, XP002741275 [X] 1,2 * the whole document *
by applicantKR0073610B
 KR100924065B
 KR20120007965
 KR101134700B
    - BINDER ET AL., GENOME BIOLOGY, (2012), vol. 13, page R40
    - MOLECULAR MICROBIOLOGY, (2005), vol. 55, no. 2, pages 368 - 380
    - VAN DER REST ET AL., APPL MICROBIOL BIOTECHNOL, (1999), vol. 52, pages 541 - 545
    - CAN. J. MICROBIOL., (1977), vol. 23, pages 1 - 6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.